跳至主要内容
临床试验/NCT04029168
NCT04029168已完成不适用

Pelvic Floor Muscles Efficiency as an Independent Factor of Therapeutic Success in the Surgical Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse

Żelazna Medical Centre, LLC1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2019年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
140
试验地点
1
主要终点
Pelvic floor organ prolapse quantification (POP-Q)

研究概览

简要总结

The aim of the study is evaluation of the efficiency of pelvic floor muscles in the context of surgical outcomes in the treatment of stress urinary incontinence and pelvic organ prolapse.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • premenopausal and postmenopausal women
  • stress urinary incontinence
  • pelvic organ prolapse

排除标准

  • previous surgical interventions due to stress urinary incontinence or pelvic organ prolapse

结局指标

主要结局

Pelvic floor organ prolapse quantification (POP-Q)

时间窗: change from the baseline till 6 month post treatment

Quantification of pelvic organ prolapse, range 0-4, higher indicate worse outcomes

Marshall-Bonney test

时间窗: change from the baseline till 6 months post treatment

Assessment of stress urinary incontinence, test can be negative or positive, positive test indicates incontinence

Pelvic Floor Distress Inventory (PFDI-20)

时间窗: change from the baseline till 6 months post treatment

Symptom inventory and a measure of the degree of bother and distress. The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300.

次要结局

  • Pelvic floor organ prolapse quantification (POP-Q)(6 months post treatment)
  • PELVIC FLOOR IMPACT QUESTIONNAIRE SHORT FORM (PFIQ-7)(change from the baseline till 12 months post treatment)
  • Pelvic Floor Distress Inventory (PFDI-20)(6 months post treatment)
  • Marshall-Bonney test(6 months post treatment)
  • Visual Analogue Scale(change from the baseline till 12 months post treatment)
  • Incontinence impact Questionnaire-Short Form (IIQ-7 SF)(change from the baseline till 12 months post treatment)

研究者

发起方
Żelazna Medical Centre, LLC
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验